Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

NCT02089854 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Female Breast Cancer

Interventions

DRUG: Toremifene; Anastrozole

Sponsor

Peking Union Medical College Hospital